Insider · CIK 0001365615

Saks Samuel R

Reports to the SEC for 8 companies · BURLINGAME, CA

sec.gov

Transactions

Companies

Filings

CIK

0001365615

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-26	PTGXProtagonist Therapeutics, IncA Award	Chief Medical Officer	AAward	+12K sh	—	—	14,000
2021-02-26	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+90K sh	—	—	90,000
2020-02-28	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+85K sh	—	—	85,000
2019-06-20	PDL BIOPHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+126K sh	$3.00	+$378K	126,050
2019-05-15	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+45K sh	—	—	45,000
2019-02-28	PTGXProtagonist Therapeutics, IncA Award	Chief Medical Officer	AAward	+2,500 sh	—	—	2,500
2019-02-28	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+15K sh	—	—	15,000
2018-06-12	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2018-06-08	PDL BIOPHARMA, INC.A Award	Director	AAward	+54.3K sh	$2.76	+$150K	214,190
2018-05-31	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2017-06-20	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2017-06-09	PDL BIOPHARMA, INC.A Award	Director	AAward	+60.7K sh	$2.47	+$150K	159,842
2017-05-27	TNXPTonix Pharmaceuticals Holding Corp.M Exercise/Conversion	Director	MExercise/Conversion	+750 sh	—	—	6,605
2017-05-27	TNXPTonix Pharmaceuticals Holding Corp. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−750 sh	—	—	0
2017-02-09	TNXPTonix Pharmaceuticals Holding Corp.M Exercise/Conversion	Director	MExercise/Conversion	+750 sh	—	—	5,855
2017-02-09	TNXPTonix Pharmaceuticals Holding Corp. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−750 sh	—	—	0
2016-06-21	TNXPTonix Pharmaceuticals Holding Corp.P Purchase	Director	PPurchase	+12.5K sh	$2.00	+$25K	51,050
2016-06-21	TNXPTonix Pharmaceuticals Holding Corp.P Purchase	Director	PPurchase	+25K sh	$2.00	+$50K	63,550
2016-06-02	PDL BIOPHARMA, INC.A Award	Director	AAward	+71K sh	$3.52	+$250K	99,113
2016-05-27	TNXPTonix Pharmaceuticals Holding Corp. · Restricted Stock UnitA Award	Director	AAward	+7,500 sh	—	—	7,500
2016-05-18	Assertio Therapeutics, IncRestricted Stock UnitsA Award	Director	AAward	+3,131 sh	—	—	3,131
2016-05-18	Assertio Therapeutics, IncStock OptionsA Award	Director	AAward	+7,669 sh	—	—	7,669
2016-05-12	Assertio Therapeutics, IncF Tax Payment	Director	FTax Payment	−734 sh	$17.52	−$12.9K	5,099
2016-02-25	TNXPTonix Pharmaceuticals Holding Corp.M Exercise/Conversion	Director	MExercise/Conversion	+600 sh	—	—	3,855
2016-02-25	TNXPTonix Pharmaceuticals Holding Corp. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−650 sh	—	—	0
2016-02-09	TNXPTonix Pharmaceuticals Holding Corp. · Restricted Stock UnitA Award	Director	AAward	+7,500 sh	—	—	7,500
2015-12-01	Assertio Therapeutics, IncF Tax Payment	Director	FTax Payment	−966 sh	$19.00	−$18.4K	2,897
2015-09-14	PDL BIOPHARMA, INC.A Award	Director	AAward	+28.1K sh	$5.34	+$150K	28,090
2015-07-17	TNXPTonix Pharmaceuticals Holding Corp.P Purchase	Director	PPurchase	+10K sh	$7.50	+$75K	32,550
2015-05-12	Assertio Therapeutics, IncStock OptionA Award	Director	AAward	+7,857 sh	—	—	7,857
2015-05-12	Assertio Therapeutics, IncRestricted Stock UnitA Award	Director	AAward	+2,936 sh	—	—	2,936
2015-05-05	Auspex Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Development Officer	DDisposition to Issuer	−7,777 sh	—	—	0
2015-05-05	Auspex Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Development Officer	DDisposition to Issuer	−30K sh	—	—	0
2015-05-05	Auspex Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Development Officer	DDisposition to Issuer	−27.2K sh	—	—	0
2015-05-05	Auspex Pharmaceuticals, Inc.U Disposition from Tender	Director, Chief Development Officer	UDisposition from Tender	−67.3K sh	—	—	0
2015-05-05	Auspex Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Development Officer	DDisposition to Issuer	−47.8K sh	—	—	0
2015-05-05	Auspex Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chief Development Officer	DDisposition to Issuer	−15K sh	—	—	0
2015-02-25	TNXPTonix Pharmaceuticals Holding Corp. · Restricted Stock UnitA Award	Director	AAward	+6,000 sh	—	—	6,000
2015-02-25	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+5,000 sh	—	—	5,000
2015-02-02	Auspex Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director, Chief Development Officer	AAward	+15K sh	—	—	15,000
2015-02-02	Auspex Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director, Chief Development Officer	AAward	+30K sh	—	—	30,000
2014-12-01	Assertio Therapeutics, IncRestricted Stock UnitA Award	Director	AAward	+3,863 sh	—	—	3,863
2014-12-01	Assertio Therapeutics, IncStock OptionA Award	Director	AAward	+9,852 sh	—	—	9,852
2014-10-29	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+5,000 sh	—	—	5,000
2014-02-11	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+5,500 sh	—	—	5,500
2014-02-10	Auspex Pharmaceuticals, Inc.P Purchase	Director, Chief Development Officer	PPurchase	+2,175 sh	$12.00	+$26.1K	63,839
2013-12-10	Assertio Therapeutics, IncStock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2013-08-14	TNXPTonix Pharmaceuticals Holding Corp.P Purchase	Director	PPurchase	+5,883 sh	—	—	22,550
2013-08-14	TNXPTonix Pharmaceuticals Holding Corp. · Series A common stock purchase warrantP Purchase	Director	PPurchase	+5,883 sh	—	—	5,883
2013-04-26	TNXPTonix Pharmaceuticals Holding Corp. · WarrantsC Conversion	Director	CConversion	−167K sh	—	—	166,667

Recent filings

Accepted (ET)
Feb 264
Saks Samuel R0001209191-21-014984
SEC(opens sec.gov)
Feb 284
Saks Samuel R0001209191-20-014100
SEC(opens sec.gov)
Jun 244
Saks Samuel R0000882104-19-000073
SEC(opens sec.gov)
May 164
Saks Samuel R0001209191-19-030616
SEC(opens sec.gov)
Mar 44
Saks Samuel R0001209191-19-015930
SEC(opens sec.gov)
Jun 134
Saks Samuel R0001615774-18-005229
SEC(opens sec.gov)
Jun 124
Saks Samuel R0000882104-18-000064
SEC(opens sec.gov)
May 314
Saks Samuel R0001209191-18-034472
SEC(opens sec.gov)
Mar 94
Saks Samuel R0001615774-18-001756
SEC(opens sec.gov)
Jun 214
Tonix Pharmaceuticals Holding Corp.0001615774-17-003294
SEC(opens sec.gov)
Jun 124
PDL BIOPHARMA, INC.0000882104-17-000066
SEC(opens sec.gov)
Jun 294/A
Tonix Pharmaceuticals Holding Corp.0001615774-16-006118
SEC(opens sec.gov)
Jun 214
Tonix Pharmaceuticals Holding Corp.0001615774-16-006000
SEC(opens sec.gov)

Companies

Address

2404 HILLSIDE DRIVE

BURLINGAME, CA, 94010